|Bid||17.36 x 800|
|Ask||17.48 x 1800|
|Day's Range||17.30 - 17.46|
|52 Week Range||9.87 - 17.72|
|Beta (5Y Monthly)||1.54|
|PE Ratio (TTM)||6.24|
|Earnings Date||Jul. 28, 2021 - Aug. 02, 2021|
|Forward Dividend & Yield||1.28 (7.33%)|
|Ex-Dividend Date||May 11, 2021|
|1y Target Est||18.35|
Hercules Capital, Inc. (NYSE: HTGC) ("Hercules" or the "Company"), will conduct its 2021 Annual Meeting of Stockholders by virtual meeting on Thursday, June 24, 2021 at 9:00 a.m. (Pacific Time). The proxy statement for the meeting was mailed separately on or about April 30, 2021 to shareholders of record as of April 23, 2021.
Let's see if Hercules Capital (HTGC) stock is a good choice for value-oriented investors right now from multiple angles.
- Principal Repayments Delayed At Least Until January 1, 2022 - Repayment Delay and Recent ATM Activity Extends Cash Runway Substantially Through the First Quarter of 2022 DUBLIN, Ireland and FORT WASHINGTON, Pa., June 03, 2021 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections, today announced that it has reached an agreement with Hercules Capita